These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31176186)

  • 41. [Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)].
    Schmidtke A; Fleckenstein P; Moises W; Beckmann H
    Schweiz Arch Neurol Psychiatr (1985); 1988; 139(2):51-65. PubMed ID: 2455937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IDS-C and IDS-sr: psychometric properties in depressed in-patients.
    Corruble E; Legrand JM; Duret C; Charles G; Guelfi JD
    J Affect Disord; 1999 Dec; 56(2-3):95-101. PubMed ID: 10701466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Rabinowitz J; Rabinowitz AA
    Psychiatry Res; 2021 Sep; 303():114114. PubMed ID: 34289425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.
    Berk M; Malhi GS; Cahill C; Carman AC; Hadzi-Pavlovic D; Hawkins MT; Tohen M; Mitchell PB
    Bipolar Disord; 2007 Sep; 9(6):571-9. PubMed ID: 17845271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia.
    Leontjevas R; van Hooren S; Mulders A
    Am J Geriatr Psychiatry; 2009 Jan; 17(1):56-64. PubMed ID: 19092312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scale.
    Iannuzzo RW; Jaeger J; Goldberg JF; Kafantaris V; Sublette ME
    Psychiatry Res; 2006 Nov; 145(1):21-37. PubMed ID: 17049379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.
    Leucht S; Fennema H; Engel RR; Kaspers-Janssen M; Lepping P; Szegedi A
    J Affect Disord; 2017 Mar; 210():287-293. PubMed ID: 28068617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fast screening of depression in cancer patients: the effectiveness of the HADS.
    Castelli L; Binaschi L; Caldera P; Mussa A; Torta R
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):528-33. PubMed ID: 20738391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge.
    Englbrecht M; Alten R; Aringer M; Baerwald CG; Burkhardt H; Eby N; Fliedner G; Gauger B; Henkemeier U; Hofmann MW; Kleinert S; Kneitz C; Krueger K; Pohl C; Roske AE; Schett G; Schmalzing M; Tausche AK; Peter Tony H; Wendler J
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):58-66. PubMed ID: 27482854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Hamilton Depression Scale (HAM-D) and the Montgomery-Åsberg Depression Scale (MADRS). A psychometric re-analysis of the European genome-based therapeutic drugs for depression study using Rasch analysis.
    Bech P; Allerup P; Larsen ER; Csillag C; Licht RW
    Psychiatry Res; 2014 Jul; 217(3):226-32. PubMed ID: 24746391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) in Colombia].
    Cano JF; Gomez Restrepo C; Rondón M
    Rev Colomb Psiquiatr; 2016; 45(3):146-55. PubMed ID: 27569008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the Reliability and Validity of the Sheehan Irritability Scale in Patients With Major Depressive Disorder.
    Khan SA; Revicki DA; Hassan M; Locklear JC; Friedman LA; Mannix S; Tummala R; Dunbar GC; Eriksson H; Sheehan DV
    J Clin Psychiatry; 2016 Aug; 77(8):1080-6. PubMed ID: 26579723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia.
    Lako IM; Bruggeman R; Knegtering H; Wiersma D; Schoevers RA; Slooff CJ; Taxis K
    J Affect Disord; 2012 Sep; 140(1):38-47. PubMed ID: 22099566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale.
    Silberman CD; Laks J; Capitão CF; Rodrigues CS; Moreira I; Engelhardt E
    Arq Neuropsiquiatr; 2006 Jun; 64(2B):407-11. PubMed ID: 16917610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating symptom domains of bipolar disorder for Spanish-speakers using the Bipolar Inventory of Symptoms Scale.
    Arnold JG; Martinez C; Zavala J; Prihoda TJ; Escamilla M; Singh V; Bazan M; Quiñones M; Bowden CL
    J Affect Disord; 2016 Nov; 205():239-244. PubMed ID: 27454409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients.
    Borza T; Engedal K; Bergh S; Benth JŠ; Selbæk G
    BMC Psychiatry; 2015 Aug; 15():191. PubMed ID: 26242794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice.
    Bondolfi G; Jermann F; Rouget BW; Gex-Fabry M; McQuillan A; Dupont-Willemin A; Aubry JM; Nguyen C
    J Affect Disord; 2010 Mar; 121(3):268-72. PubMed ID: 19660815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients' perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care.
    Wikberg C; Pettersson A; Westman J; Björkelund C; Petersson EL
    Scand J Prim Health Care; 2016 Dec; 34(4):434-442. PubMed ID: 27804312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical validation of the Psychotic Depression Assessment Scale (PDAS) against independent global severity ratings in older adults.
    Vermeulen T; Lemey L; Van Diermen L; Schrijvers D; Madani Y; Sabbe B; Van Den Bossche MJA; van der Mast RC; Østergaard SD
    Acta Neuropsychiatr; 2018 Aug; 30(4):203-208. PubMed ID: 29501075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?
    Zimmerman M; Walsh E; Friedman M; Boerescu DA; Attiullah N
    J Affect Disord; 2018 Jan; 225():449-452. PubMed ID: 28858659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.